medigraphic.com
ISSN 0035-0052 (Print)

2001, Number 4

<< Back Next >>

Rev Mex Pediatr 2001; 68 (4)

Adverse reactions due to double viral vaccine (measles/rubella) in university students from Minatitlan, Mexico

Rodríguez-Guzmán LM, de la Paz PC, Estrella-Chulim JL, Pérez-López D, Rodríguez-García R

Language: Spanish
References: 12
Page: 139-142
PDF size: 63.18 Kb.


ABSTRACT

Aim. To report the adverse reactions associated to a double viral vaccine (DVV) measles/rubella.
Material and methods. A survey was done in 261 infirmary students, which were vaccinated 15 days before with DVV.
Results. One hundred and eighty one (69.3%) had at least a single reaction, but most of them were related to the place of the injection; 17 (6.5%) had rash, 36 (13.8%) fever, 31 (11.9%) rhinitis and 21 (8.0%) cough.
Conclusions. It is recommended that before the vaccination the population most be informated about the adverse reaction.


REFERENCES

  1. Gutiérrez-Trujillo G. Vacunación antirrubeólica: La vacuna y las estrategias. En: Escobar A Editores. 1992 Vacunas ciencia y salud. México, D.F.: Secretaría de Salud, 1992: 217-223.

  2. Kumate J. Vacuna de la rubéola. Bol Med Hosp Infant Mex 1999; 56: 58-61.

  3. American Academy of Pediatrics. Sarampión. En: Peter G, editor. 1997 Red Book. (24.a ed.). Elk Grove Village. IL American Academy of Pediatrics, 1997: 493-507.

  4. American Academy of Pediatrics. Rubéola En: Peter G, editor. 1997 Red Book. (24.a ed.). Elk Grove Village. IL: American Academy of Pediatrics, 1997: 480-486.

  5. Bakshi SS, Cooper LZ. Vacunas contra rubéola y parotiditis. Clin Ped North Am 1990; 3: 693-710.

  6. Markowitz LE, Orenstein WA. Vacunas contra el sarampión. Clin Ped North Am 1990; 3: 645-668.

  7. Academia Mexicana de Pediatría. Vacuna contra el sarampión. En: Macías M, editores Inmunizaciones. (la ed.) México, D.F. 1996: 17-20.

  8. Academia Mexicana de Pediatría. Vacuna contra la rubéola. En: Macías M, editores Inmunizaciones. (1a ed.) México, D.F. 1996: 23-25.

  9. Weibel RE, Stokes J, Buynak EB, Hilleman MR. Influence of age on clinical response to HPV-77 duck rubella vaccine. JAMA 1972; 202: 805-807.

  10. Swartz TA, Klingber W, Goldwasser RA, Klingber MA, Goldblum N, Hilleman MR. Clinical manifestations, according to age, among females given BPV-77 duck rubella vaccine. Am J Epidemiol 1971; 94: 241-246.

  11. Davis RL, Marcuse E, Black S, Shinefield H, Givens B, Schwalbe J y col. Administración de la segunda dosis de la vacuna triple vírica entre los 4-5 y los 10-12 años de edad. Comparación de las reacciones clínicas adversas después de la inmunización en la Vaccine Safety Datalink Project. (ed. esp.) Pediatrics 44: 319-324.

  12. Aquino-Díaz Y, León-Cruz A. Prevalencia de anticuerpos de toxoplasma y rubéola en mujeres embarazadas. V Reunión de Investigación Médica de la Región Sur, IMSS 2000; 39: 18.




2020     |     www.medigraphic.com